SCHEMBL156202

SCHEMBL156202

CC1CCN(Cc2ccc(Cl)cc2)CC1

nearest known ligand 0.76

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 5/20 0.76
ACHE P22303 3/20 0.70
ALDH1A1 P00352 3/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
KDM4E B2RXH2 1/20 0.60
SIGMAR1 Q99720 5/20 0.58
MITF O75030 1/20 0.55
RAB9A P51151 1/20 0.55
BCHE P06276 1/20 0.54
BACE1 P56817 1/20 0.54
CXCR3 P49682 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20232771 0.89 HRH3 (0.61) HRH3ACHEALDH1A1MEN1KMT2A
SCHEMBL8275450 0.85 HRH3 (0.76) HRH3ACHEALDH1A1MEN1KMT2A
SCHEMBL8252094 0.85 HRH3 (0.76) HRH3ACHEALDH1A1MEN1KMT2A
SCHEMBL17465246 0.84 HRH3 (0.69) HRH3ACHEALDH1A1MEN1KMT2A
SCHEMBL17828185 0.84 HRH3 (0.75) HRH3ACHESIGMAR1
SCHEMBL3861163 0.83 HRH3 (0.73) HRH3ACHEALDH1A1SIGMAR1
SCHEMBL3004249 0.83 HRH3 (0.73) HRH3ACHEALDH1A1SIGMAR1CXCR3
SCHEMBL5411899 0.83 HRH3 (0.73) HRH3ACHEBCHEBACE1
SCHEMBL6975680 0.83 HRH3 (0.73) HRH3ACHEALDH1A1SIGMAR1BCHE
SCHEMBL18908952 0.83 ACHE (0.62) HRH3ACHEALDH1A1KDM4ESIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020251012-A1 NOVEL 1-BENZYLAMINE DERIVATIVE AND AGRICULTURAL AND HORTICULTURAL AGENT USING SAME AS ACTIVE INGREDIENT アグロカネショウ株式会社 2020-12-17 WO disclosed
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20070265289-A1 2-Aminopyrimidine Derivative ASTELLAS PHARMA INC. (JP) 2007-11-15 US disclosed
US-20070265289-A1 2-Aminopyrimidine Derivative ASTELLAS PHARMA INC. (JP) 2007-11-15 US disclosed
US-7262212-B2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-28 US disclosed
US-7262212-B2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-28 US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 HRH3 303/4885ACHE 3708/4885ALDH1A1 2458/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 HRH3 303/4885ACHE 3708/4885ALDH1A1 2458/4885
US-20070265289-A1 2-Aminopyrimidine Derivative NFKBIA, IKBKG, NFKB2 HRH3 1234/4885ACHE 3533/4885ALDH1A1 2714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.